Patent: RE42704
✉ Email this page to a colleague
Summary for Patent: RE42704
Title: | Production of fibrinogen in transgenic animals |
Abstract: | Materials and methods for producing fibrinogen in transgenic non-human mammals are disclosed. DNA segments encoding A.alpha., B.beta. and .gamma. chains of fibrinogen are introduced into the germ line of a non-human mammal, and the mammal or its female progeny produces milk containing fibrinogen expressed from the introduced DNA segments. Non-human mammalian embryos and transgenic non-human mammals carrying DNA segments encoding heterologous fibrinogen polypeptide chains are also disclosed. |
Inventor(s): | Prunkard; Donna E. (Seattle, WA), Foster; Donald C. (Lake Forest Park, WA) |
Assignee: | Pharming Intellectual Property B.V. (Al Leiden, NL) |
Application Number: | 09/232,488 |
Patent Claims: | see list of patent claims |
Details for Patent RE42704
Applicant | Tradename | Biologic Ingredient | Dosage Form | BLA | Approval Date | Patent No. | Expiredate |
---|---|---|---|---|---|---|---|
Csl Behring Gmbh | RIASTAP | fibrinogen concentrate (human) | For Injection | 125317 | 01/16/2009 | ⤷ Try a Trial | 2040-01-28 |
Octapharma Pharmazeutika Produktionsges.m.b.h. | FIBRYGA, FIBRYNA | fibrinogen (human) | For Injection | 125612 | 06/07/2017 | ⤷ Try a Trial | 2040-01-28 |
>Applicant | >Tradename | >Biologic Ingredient | >Dosage Form | >BLA | >Approval Date | >Patent No. | >Expiredate |